Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 22 of 27
 |<   <<   <  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27

Scientific Advancements
Tuesday, November 13, 2018   (0 Comments - view/add)
KemPharm Enhances Pipeline with the Addition of KP879, a Potential New Treatment for Stimulant Use D »
KemPharm Enhances Pipeline with the Addition of KP879, a Potential New Treatment for Stimulant Use Disorder Novem...
Tuesday, October 30, 2018   (0 Comments - view/add)
FebriDx® Receives Updated CE Mark to Allow Incorporation of All-in-One Test Format »
FebriDx® Receives Updated CE Mark to Allow Incorporation of All-in-One Test Format RPS D...
Monday, October 29, 2018   (0 Comments - view/add)
Avance® Nerve Graft Receives Regenerative Medicine Advanced Therapy (RMAT) Designation »
Avance® Nerve Graft Receives Regenerative Medicine Advanced Therapy (RMAT) Designation RMAT Designation reinforces c...
Monday, October 29, 2018   (0 Comments - view/add)
TherapeuticsMD Announces FDA Approval of TX-001HR: BIJUVA™ (Estradiol and Progesterone) Capsules for »
TherapeuticsMD Announces FDA Approval of TX-001HR: BIJUVA™ (Estradiol and Progesterone) Capsules for the Treatment of Mode...
Tuesday, October 23, 2018   (0 Comments - view/add)
KemPharm and twoXAR Announce Technology Collaboration to Develop Prodrug-Based Therapies for Multipl »
KemPharm and twoXAR Announce Technology Collaboration to Develop Prodrug-Based Therapies for Multiple Indications &n...
Wednesday, October 17, 2018   (0 Comments - view/add)
Oragenics, Inc. Receives Clearance to Enroll Patients in Belgium into Its Phase 2 Clinical Trial of »
Oragenics, Inc. Receives Clearance to Enroll Patients in Belgium into Its Phase 2 Clinical Trial of AG013 for Oral Mucosit...
Tuesday, October 16, 2018   (0 Comments - view/add)
Medtronic launches workflow system to help wean patients off oral opioids »
Medtronic launches workflow system to help wean patients off oral opioids Sarah Faulkner October 16, 201...
Monday, October 15, 2018   (0 Comments - view/add)
CTD Holdings Announces Plans to Broaden its Expanded Access Program for Trappsol® Cyclo™ »
CTD Holdings Announces Plans to Broaden its Expanded Access Program for Trappsol® Cyclo™ Company expects to provide...
Thursday, October 11, 2018   (0 Comments - view/add)
ADMA Biologics Provides Regulatory Update for BIVIGAM® »
ADMA Biologics Provides Regulatory Update for BIVIGAM®     RAMSEY, N.J. and BOCA RATON, Fla., Oct. 11,...
Friday, October 5, 2018   (0 Comments - view/add)
CTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo »
CTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo™ for Treatment of Nie...
Wednesday, October 3, 2018   (0 Comments - view/add)
CTD announces encouraging top-line data from two ongoing clinical trials of Trappsol® Cyclo™ adminis »
CTD announces encouraging top-line data from two ongoing clinical trials of Trappsol® Cyclo™ administered intravenously in...
Wednesday, October 3, 2018   (0 Comments - view/add)
MPFI Scientist Wins $6.8 Million NIH Grant For Breakthrough Technique to Map Neuromodulators Within »
For Immediate Release Media Contact: Katie Edwards, Head of Public Communications [email protected]...
Tuesday, October 2, 2018   (0 Comments - view/add)
Wednesday, September 26, 2018   (0 Comments - view/add)
Brammer Bio announces progress on $200 million program to advance gene therapies »
Brammer Bio announces progress on $200 million program to advance gene therapies   CAMBRIDGE, Mass. , Sept....
Wednesday, September 19, 2018   (0 Comments - view/add)
Bascom Palmer Treats First U.S. Patient in Nightstar Gene Therapy Clinical Trial for X-Linked Retini »
Bascom Palmer Treats First U.S. Patient in Nightstar Gene Therapy Clinical Trial for X-Linked Retinitis Pigmentosa MIA...
Tuesday, September 18, 2018   (0 Comments - view/add)
New diabetic pump for kids now available for type 1 diabetes »
New diabetic pump for kids now available for type 1 diabetes   Reporter:Channing Frampton Published:...
Monday, September 17, 2018   (0 Comments - view/add)
Stuart Therapeutics Announces Positive Pre-Clinical Results for its Dry Eye Therapeutic »
Stuart Therapeutics Announces Positive Pre-Clinical Results for its Dry Eye Therapeutic September 17th, 2018, Stuart...
Monday, September 17, 2018   (0 Comments - view/add)
Opioid users could benefit from meth-relapse prevention strategy, study finds »
For Immediate Release   Opioid users could benefit from meth-relapse prevention strategy, study finds...
Sunday, September 9, 2018   (0 Comments - view/add)
KynderMed, Inc. begins an important clinical study at Tampa General Hospital to advance the company’ »
KynderMed, Inc. begins an important clinical study at Tampa General Hospital to advance the company’s light therapy techno...
Thursday, August 30, 2018   (0 Comments - view/add)
CTD Holdings Discusses its Phase I Clinical Trial for Intravenous Use of Trappsol® Cyclo™ in Niemann »
CTD Holdings Discusses its Phase I Clinical Trial for Intravenous Use of Trappsol® Cyclo™ in Niemann-Pick Disease Type C...
Tuesday, August 28, 2018   (0 Comments - view/add)
FAU study highlights how muscle mass and brain health are connected »
FAU study highlights how muscle mass and brain health are connected   By Steve Dorfman , Palm Beach Post...
Monday, August 27, 2018   (0 Comments - view/add)
Cantex Pharmaceuticals, Inc. Receives FDA Fast Track Designation For CX-01 For The Treatment Of Pati »
Cantex Pharmaceuticals, Inc. Receives FDA Fast Track Designation For CX-01 For The Treatment Of Patients Over Age 60 With...
Monday, August 27, 2018   (0 Comments - view/add)
Morphogenesis, Inc Celebrates Advancement into Human Clinical Trials »
FOR IMMEDIATE RELEASE Media Contact: Amber Brinkley Kippen Communications amber@kippencommunications....
Wednesday, August 22, 2018   (0 Comments - view/add)
Jupiter Orphan Therapeutics Announces Favorable Data Which Expands JOTROL's Applications to the Esti »
Jupiter Orphan Therapeutics Announces Favorable Data Which Expands JOTROL's Applications to the Estimated $5 Billion Mitoc...
Thursday, August 16, 2018   (0 Comments - view/add)
FDA approves new diabetic pump for use in kids »
FDA approves new diabetic pump for use in kids MiniMed 670g system approved for use in Type 1 diabetics ages 7 & olde...
Wednesday, August 15, 2018   (0 Comments - view/add)
Oragenics, Inc. Resumes Phase 2 Clinical Trial of AG013 in Oral Mucositis Following Positive Routine »
Oragenics, Inc. Resumes Phase 2 Clinical Trial of AG013 in Oral Mucositis Following Positive Routine Safety Review &nb...
Monday, August 13, 2018   (0 Comments - view/add)
CTD Holdings Announces Expanded Access Protocol using Intravenous Trappsol® Cyclo™ for Alzheimer’s D »
CTD Holdings Announces Expanded Access Protocol using Intravenous Trappsol® Cyclo™ for Alzheimer’s Disease   P...
Wednesday, August 1, 2018   (0 Comments - view/add)
Xcovery Announces First Cohort of Patients Dosed in a Phase 1/2 Clinical Trial of Vorolanib in Combi »
Xcovery Announces First Cohort of Patients Dosed in a Phase 1/2 Clinical Trial of Vorolanib in Combination with Nivolumab...
Tuesday, July 24, 2018   (0 Comments - view/add)
Ology Bioservices and RAFA Laboratories Announce FDA Approval of the Atropine Autoinjector as a Medi »
Ology Bioservices and RAFA Laboratories Announce FDA Approval of the Atropine Autoinjector as a Medical Countermeasure for...
Monday, July 23, 2018   (0 Comments - view/add)
AGTC Treats First Patient of Second Cohort in Phase 1/2 Clinical XLRP Study; Earns $10 Million Enrol »
AGTC Treats First Patient of Second Cohort in Phase 1/2 Clinical XLRP Study; Earns $10 Million Enrollment Milestone...
Wednesday, July 18, 2018   (0 Comments - view/add)
ObvioHealth Announces Mobile Application to Transform Clinical Studies »
ObvioHealth Announces Mobile Application to Transform Clinical Studies The medtech company offers a digital solu...
Friday, July 13, 2018   (0 Comments - view/add)
So far, so good. Doctors at Tampa General find success with a device that fights often-fatal aneurys »
So far, so good. Doctors at Tampa General find success with a device that fights often-fatal aneurysms   TAMPA...
Wednesday, July 11, 2018   (0 Comments - view/add)
Captozyme Initiates Clinical Study of Nephure™ Oxalate-Reducing Enzyme »
FOR IMMEDIATE RELEASE   Captozyme Initiates Clinical Study of Nephure™ Oxalate-Reducing Enzyme...
Monday, July 9, 2018   (0 Comments - view/add)
KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD »
KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD   Jul...
Thursday, July 5, 2018   (0 Comments - view/add)
Effective, High-quality Curcumin Enters Health Marketplace »
Effective, High-quality Curcumin Enters Health Marketplace VOLT03 by Nutent Therapeutics Delivers Pharmaceutical-grade...

Displaying page 22 of 27
 |<   <<   <  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27

About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 8,600 establishments and research organizations in the BioPharma, MedTech, Digital Health and Health Systems that collectively employ nearly 107,000 Floridians. Source: TEConomy/BIO (released 2022)